Biodefense Global Industry Overview 2021-2030: AI and Machine Learning to Revolutionize Early Detection and Response [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
The global Biodefense market is estimated at US$18.2 billion in 2024 and is anticipated to register a CAGR of 8.6% during the 2024-2030 analysis period and stand at a projected US$29.9 billion by 2030. Biodefense aims to reduce the impact of biological agents and ensure readiness for potential biological emergencies. This requires collaboration among bioscience labs, hospitals, customs, and public health sectors to prevent the use of dangerous pathogens and toxins. The Biodefense market is driven by technological advancements, rising global health hazards, and substantial government investments. Key drivers include the rapid development of next-generation vaccines and treatments; with artificial intelligence (AI) and machine learning (ML) enhancing early detection and response systems; advances in biodetection technology and point-of-care diagnostics improve outbreak response and early warning capabilities; biosecurity measures are strengthening research facilities and high-risk
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at William Blair.MarketBeat
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $400.00 price target on the stock.MarketBeat
- Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $296.00 price target on the stock.MarketBeat
- ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study [Yahoo! Finance]Yahoo! Finance
- High Growth Tech Stocks To Watch This November 2024 [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 10/31/24 - Beat
ALNY
Sec Filings
- 11/12/24 - Form SC
- 11/8/24 - Form SC
- 10/31/24 - Form 10-Q
- ALNY's page on the SEC website